Trailing-twelve-month (TTM) revenue is $5.90 Million with a year-over-year growth of (23.17%). Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $1,446,066 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-14 |
| Q4 FY2025Period ended 2025-12-31 | $1,592,813 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-03-16 |
| Q1 FY2026Period ended 2026-03-31 | $1,351,527 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-11 |
| Q2 FY2026Period ended 2026-06-30 | $1,510,579 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-07 |
| TTM revenue | $5,900,985 |
Current P/S: $2,576,057 market capitalization ÷ $5,900,985 TTM revenue = 0.44x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T15:00:29.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $1.51M.
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 8 comparable quarters.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T15:01:39.208Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|
| Health Care, Other | $19,324 | N/A | N/A |
| Health Care, Patient Service | N/A | $516,000 | $5M |
| Other Revenues | $21,515 | N/A | $4,860 |
$5.90M
$5.90 Million
(23.17%)
vs. $7.68M a year ago (TTM)
+524.87%
3 Year compound annual growth rate
1 Year
(23.17%)
3 Year
+524.87%
5 Year
N/A
10 Year
N/A
15 Year
N/A
20 Year
N/A
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $6.16M | ($3.20M) | (34.18%) |
| 2024 | $9.36M | +$6.83M | +269.75% |
| 2023 | $2.53M | +$2.53M | +52617.05% |
TTM Growth
(23.17%)
3-Year CAGR
+524.87%
5-Year CAGR
N/A
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T15:01:39.208Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
